| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-07 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
8e-07 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
1e-05 |
| mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
6e-05 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
8e-05 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.0003 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |